Hemostasis Today

October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Mahdieh Dagina Pedersen: A Meaningful Milestone in Hemophilia A Research and Oral Drug Development
Oct 14, 2026, 06:55

Mahdieh Dagina Pedersen: A Meaningful Milestone in Hemophilia A Research and Oral Drug Development

Mahdieh Dagina Pedersen, Advanced Filling Professional at Novo Nordisk, shared a post on LinkedIn about a recent article she an her colleagues co-authored, published in Blood, adding:

“A proud and meaningful milestone!

Seeing our work published in Blood feels very special.

I’m grateful to have contributed to this research alongside my former colleagues at Novo Nordisk, exploring new possibilities for the treatment of hemophilia A.

With my background in oral formulation and manufacturing, this project holds particular meaning for me.

Oral drug development has been an important part of my career at Novo Nordisk and remains a field I’m deeply passionate about.

Thank you to my co-authors and former colleagues for the collaboration and everything I learned along the way.”

Title: Development of Inno8, an orally administered factor VIIIa-mimetic antibody fragment for treatment of hemophilia A

Authores: Jacob LundCorresponding Author, Jais Rose Bjelke, Daniele Granata, Thomas Egebjerg, Pierre-Louis Bardonnet, Zoey Wang Zhuoran, Eva Johansson, Bjarne Rask Poulsen, Jakob Borre Dahl Nissen, Philip Jonas Sassene, Per Franklin Nielsen, Lars Jørgensen, Mads Bjelke, Pingping Chen, Sr., Esther Bloem, Mette Loftager, Kasper Lamberth, Katharina L. Kopp, Helle Demuth, Per-Olof Wahlund, Mie Mandal Mortensen, Birgitte Nissen, Mahdieh Dagina Pedersen, Emma Balantic-Nielsen, Michael Monrad Grandal, Anne Westall, Andreas Vegge

Mahdieh Dagina Pedersen: A Meaningful Milestone in Hemophilia A Research and Oral Drug Development

Stay updated on all scientific advances with Hemostasis Today.